Search Results - "Dinkelborg, Ludger M."
-
1
Specific PET Imaging of xC― Transporter Activity Using a 18F-Labeled Glutamate Derivative Reveals a Dominant Pathway in Tumor Metabolism
Published in Clinical cancer research (15-09-2011)“…(18)F-labeled small molecules targeting adaptations of tumor metabolism possess the potential for early tumor detection with high sensitivity and specificity…”
Get full text
Journal Article -
2
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies
Published in PloS one (18-02-2016)“…(S)-4-(3-[18F]Fluoropropyl)-L-glutamic acid (18F-FSPG) is a novel radiopharmaceutical for Positron Emission Tomography (PET) imaging. It is a glutamate…”
Get full text
Journal Article -
3
18F-Radiolabeling of Aromatic Compounds Using Triarylsulfonium Salts
Published in European Journal of Organic Chemistry (01-02-2012)“…A new method for the 18F‐radiolabeling of aromatic compounds based on the aromatic nucleophilic substitution (SNAr) reaction using triarylsulfonium salts has…”
Get full text
Book Review Journal Article -
4
Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability
Published in Nuclear medicine and biology (01-08-2014)“…Abstract Introduction Atherosclerotic plaque rupture is the primary cause for myocardial infarction and stroke. During plaque progression macrophages and mast…”
Get full text
Journal Article -
5
Radioimmunotherapy of Solid Tumors by Targeting Extra Domain B Fibronectin: Identification of the Best-Suited Radioimmunoconjugate
Published in Clinical cancer research (01-10-2005)“…Purpose: The expression of extra domain B (ED-B) fibronectin is always associated with angiogenic processes and can be exclusively observed in tissues…”
Get full text
Journal Article Conference Proceeding -
6
Molecular imaging in drug development
Published in Nature reviews. Drug discovery (01-07-2008)“…Key Points Drug development is a costly, time-intensive and high-risk endeavour, with only two to three approvals for novel therapeutics in new drug classes…”
Get full text
Journal Article -
7
Bispecific Antibody Pretargeting of Tumor Neovasculature for Improved Systemic Radiotherapy of Solid Tumors
Published in Clinical cancer research (15-09-2006)“…Purpose: Extra domain B (ED-B) fibronectin is a specific tumor matrix marker for targeting angiogenesis in solid tumors. In this study, the radiotherapeutic…”
Get full text
Journal Article -
8
Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study
Published in Journal of neurology, neurosurgery and psychiatry (01-04-2015)“…Background We assessed the clinical utility of β-amyloid (Aβ) imaging with 18F-florbetaben (FBB) in mild cognitive impairment (MCI) by evaluating its…”
Get full text
Journal Article -
9
18 F-FSPG PET/CT Imaging of System x C - Transporter Activity in Patients with Primary and Metastatic Brain Tumors
Published in Radiology (01-06-2022)“…Background The PET tracer (4S)-4-(3-[ F]fluoropropyl)-l-glutamate ( F-FSPG) targets the system x cotransporter, which is overexpressed in various tumors…”
Get full text
Journal Article -
10
18F-FSPG PET/CT Imaging of System xC- Transporter Activity in Patients with Primary and Metastatic Brain Tumors
Published in Radiology (01-06-2022)Get full text
Journal Article -
11
Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for Imaging xC― Transporter Using Positron Emission Tomography in Patients with Non―Small Cell Lung or Breast Cancer
Published in Clinical cancer research (01-10-2012)“…(4S)-4-(3-[(18)F]fluoropropyl)-l-glutamate (BAY 94-9392, alias [(18)F]FSPG) is a new tracer to image x(C)(-) transporter activity with positron emission…”
Get full text
Journal Article -
12
Tau PET imaging with 18 F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study
Published in Journal of Nuclear Medicine (01-06-2020)“…F-PI-2620 is a PET tracer with high binding affinity for aggregated tau, a key pathologic feature of Alzheimer disease (AD) and other neurodegenerative…”
Get full text
Journal Article -
13
Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study
Published in The Journal of nuclear medicine (1978) (01-06-2020)“…18F-PI-2620 is a PET tracer with high binding affinity for aggregated tau, a key pathologic feature of Alzheimer disease (AD) and other neurodegenerative…”
Get full text
Journal Article -
14
Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of 18 F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain
Published in Journal of Nuclear Medicine (01-06-2020)“…F-PI-2620 is a next-generation tau PET tracer that has demonstrated ability to image the spatial distribution of suspected tau pathology. The objective of this…”
Get full text
Journal Article -
15
Evaluation of Dosimetry, Quantitative Methods, and Test–Retest Variability of 18F-PI-2620 PET for the Assessment of Tau Deposits in the Human Brain
Published in The Journal of nuclear medicine (1978) (01-06-2020)“…18F-PI-2620 is a next-generation tau PET tracer that has demonstrated ability to image the spatial distribution of suspected tau pathology. The objective of…”
Get full text
Journal Article -
16
(S)-4-(3-18F-fluoropropyl)-L-glutamic acid: an 18F-labeled tumor-specific probe for PET/CT imaging--dosimetry
Published in The Journal of nuclear medicine (1978) (01-06-2013)“…The glutamic acid derivative (S)-4-(3-(18)F-Fluoropropyl)-l-glutamic acid ((18)F-FSPG, alias BAY 94-9392), a new PET tracer for the detection of malignant…”
Get full text
Journal Article -
17
Commentary to 18 F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots-Are We Getting There?
Published in Molecular imaging (01-01-2018)“…Thrombus formation can lead to heart attacks, stroke and pulmonary embolism, which are major causes of mortality. Current standard diagnostic imaging methods…”
Get full text
Journal Article -
18
Commentary to 18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots—Are We Getting There?
Published in Molecular imaging (01-01-2018)“…Thrombus formation can lead to heart attacks, stroke and pulmonary embolism, which are major causes of mortality. Current standard diagnostic imaging methods…”
Get full text
Journal Article -
19
Exploratory Clinical Investigation of (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate PET of Inflammatory and Infectious Lesions
Published in Journal of Nuclear Medicine (01-01-2016)“…We explored system [Formula: see text] transporter activity and the detection of inflammatory or infectious lesions using…”
Get full text
Journal Article -
20
Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer
Published in European journal of nuclear medicine and molecular imaging (01-01-2014)“…Prostate-specific membrane antigen (PSMA) is a transmembrane protein overexpressed in prostate cancer and is therefore being explored as a biomarker for…”
Get full text
Journal Article